Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Life & Banc Split Corp T.LBS

Alternate Symbol(s):  LFBCF | T.LBS.P.A

Life & Banc Split Corp. (the Fund) is a Canada-based mutual fund company. The Fund's investment objective is to provide holders of Preferred shares with fixed cumulative preferential quarterly cash distributions and to return the original issue price on the maturity date, and to provide holders of Class A shares with regular monthly cash distributions and the opportunity for capital... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:LBS)

Life & Banc Split Corp. Completes Treasury Offering

GlobeNewswire 9 days ago

Life & Banc Split Corp. Announces Successful Overnight Offering

GlobeNewswire April 18, 2024

Canadian Investment Regulatory Organization Trade Resumption - LBS

Canada NewsWire April 18, 2024

Canadian Investment Regulatory Organization Trading Halt - LBS

Canada NewsWire April 17, 2024

LIFE & BANC SPLIT CORP. ANNOUNCES OVERNIGHT OFFERING

Canada NewsWire April 17, 2024

Life & Banc Split Corp. Renews At-The-Market Equity Program

GlobeNewswire January 19, 2024

Life & Banc Split Corp. Completes Treasury Offering

GlobeNewswire December 19, 2023

Life & Banc Split Corp. Announces Successful Overnight Offering

GlobeNewswire December 12, 2023

Canadian Investment Regulatory Organization Trade Resumption - LBS

Canada NewsWire December 12, 2023
View More News ››

Opinion & Analysis (TSX:LBS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:LBS)

Unfortunate that LBS moved GWO and IAG to the bottom

I just looked at the weightings and IAG is 10th while GWO is the 8th of the 10 weightings in LBS.. TD is the biggest loser for the fund...
mouserman - 1 day ago

LBS unit nav comes in @ $17.13 after distributions

So my previous estimate was correct but did not take off the distributions to commons.
mouserman - 1 day ago

LBS unit nav to May 2 = $71.23

I am guessing the UNIT NAV saw a gain of about 10 cents since the update a week ago. Will see what Brompton's numbers look like...
mouserman - 2 days ago

LBS unit nav to May 1 = approx: $17.20

Showing a gain of 7 cents in UNT NAV since thursday.
mouserman - 3 days ago

LBS unit nav to April 29= approx: $17.22

Showing a gain of 9 cents since thursday update.
mouserman - 5 days ago

LBS unit nav to APril 25 reported @ $17.13

Not sure how the spreadsheet could be out that much in a week, and eith an offering. Perhaps it was a negative effect on UNIT NAV...
mouserman - 8 days ago
View more Bullboard ››

NurExone Biologic Inc.

NurExone Biologic Inc.

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ...
View More »